2017-2025 World Neuromyelitis Optica Drug Market Research Report (by Product Type, End-User / Application and Regions / Countries)
- HEY3402252
- 116 Pages
- December 2019
- Healthcare
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Neuromyelitis Optica Drug , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Neuromyelitis Optica Drug market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Production Market Share
Price Rage
Cost
By End-User / Application
Acute attack
Remission prophylactic treatment
By Company
Pfizer
FRESENIUS
TEVA
SANDOZ
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Capstone Pfizer
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 FRESENIUS
12.3 TEVA
12.4 SANDOZ
12.5 Intas
12.6 Gyjtrs
12.7 NANG KUANG
12.8 Tianjin Kingyork
12.9 Baxter
12.10 CSL
12.11 Grifols
12.12 Octapharma
12.13 CBOP
13 Price Overview
13.1 Price Segment
13.2 Price Trend
14 Research Conclusion
Table Global Neuromyelitis Optica Drug Market and Growth by Type
Table Global Neuromyelitis Optica Drug Market and Growth by End-Use / Application
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Revenue Share by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Type (2020-2025)
Table Global Neuromyelitis Optica DrugMarket Share by Forecast Type (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Volume, Price, Cost and Margin of CBOP
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
